메뉴 건너뛰기
Drugs
Volumn 58, Issue SUPPL. 2, 1999, Pages 209-210
Susceptibility of Pseudomonas aeruginosa isolates from cystic fibrosis patients to ciprofloxacin
Author keywords

[No Author keywords available]
Indexed keywords

CIPROFLOXACIN;
EID: 0032734798     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-199958002-00063     Document Type: Conference Paper
Times cited : (1)
References (7)
  • 1
    • 0031063066 scopus 로고    scopus 로고
    • Microbiological background for anti-Pseudomonos aeruginosa vaccination in cystic fibrosis
    • Bauernfeind A, Przyklenk B. Microbiological background for anti-Pseudomonos aeruginosa vaccination in cystic fibrosis. Behring Inst Mitt 1997; 98: 256-61
    • (1997) Behring Inst Mitt , vol.98 , pp. 256-261
    • Bauernfeind, A.1    Przyklenk, B.2
  • 2
    • 0030831857 scopus 로고    scopus 로고
    • Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin, and ciprofloxacin
    • Bauernfeind A. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin, and ciprofloxacin. J Antimicrob Chemother 1997; 40: 639-51
    • (1997) J Antimicrob Chemother , vol.40 , pp. 639-651
    • Bauernfeind, A.1
  • 3
    • 0026345698 scopus 로고
    • Comparative pharmacokinetic disposition of fluoroquinolones in the lung
    • Wise R, Baldwin DR, Andrews JM, et al. Comparative pharmacokinetic disposition of fluoroquinolones in the lung. J Antimicrob Chemother 1991; 28 Suppl. C: 65-71
    • (1991) J Antimicrob Chemother , vol.28 , Issue.SUPPL. C , pp. 65-71
    • Wise, R.1    Baldwin, D.R.2    Andrews, J.M.3
  • 4
    • 0001893471 scopus 로고
    • Therapy of respiratory tract infections with quinolone antimicrobial agents
    • Hooper DC, Wolfson JS, editors. Washington, DC: American Society for Microbiology
    • Scully BE. Therapy of respiratory tract infections with quinolone antimicrobial agents. In: Hooper DC, Wolfson JS, editors. Quinolone antimicrobial agents. 2nd ed. Washington, DC: American Society for Microbiology, 1993: 339-62
    • (1993) Quinolone Antimicrobial Agents. 2nd Ed. , pp. 339-362
    • Scully, B.E.1
  • 5
    • 0029921514 scopus 로고    scopus 로고
    • Improved survival in the Danish center-treated cystic fibrosis patients: Results of aggressive treatment
    • Frederiksen B, Lanng S, Koch C, et al. Improved survival in the Danish center-treated cystic fibrosis patients: results of aggressive treatment. Pediatr Pulmonol 1996; 21: 153-8
    • (1996) Pediatr Pulmonol , vol.21 , pp. 153-158
    • Frederiksen, B.1    Lanng, S.2    Koch, C.3
  • 6
    • 0344428996 scopus 로고    scopus 로고
    • Comparative microbiological effects of combination therapy with ciprofloxacin plus colistin vs monotherapy with ciprofloxacin or colistin against Pseudomonas aeruginosa
    • Munich, Germany. Monatsschr Kinderheilkd
    • Bauernfeind A, Eberlein E, Reinhardt D, et al. Comparative microbiological effects of combination therapy with ciprofloxacin plus colistin vs monotherapy with ciprofloxacin or colistin against Pseudomonas aeruginosa [abstract P12]. International Cystic Fibrosis Symposium, Munich, Germany. Monatsschr Kinderheilkd, 1996; 144: 1042
    • (1996) International Cystic Fibrosis Symposium , vol.144 , pp. 1042
    • Bauernfeind, A.1    Eberlein, E.2    Reinhardt, D.3
  • 7
    • 0027266917 scopus 로고
    • Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis
    • Govan JRW, Brown PH, Maddison J, et al. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 1993; 342: 15-9
    • (1993) Lancet , vol.342 , pp. 15-19
    • Govan, J.R.W.1    Brown, P.H.2    Maddison, J.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.